|Cloning, Stem Cells Long Mired In Legislative Gridlock[Quotes CGS's Marcy Darnovsky], NPRMay 16th, 2013The news that U.S. scientists have successfully cloned a human embryo seems almost certain to rekindle a political fight that has raged, on and off, since the announcement of the creation of Dolly the sheep in 1997.|
|Critiquing the Stem Cell Board[Editorial]Los Angeles TimesFebruary 27th, 2013California's stem cell institute is finally making some changes, but the modifications are more a bandage than a cure. Like a bandage, they will probably do, but only for a limited time.|
|Billionaires Anoint Biogeeks, ForbesFebruary 20th, 2013A group of Silicon Valley billionaires announced awards of $3 million to each of eleven recipients, in the first round of their "Breakthrough Prize in Life Sciences."|
|Moore is LessWhy the Development of Pluripotent Stem Cells Might Lead Us to Rethink Differential Property Interests in Excised Human Cells, Stanford Technology Law ReviewJanuary 15th, 2013A proposal for addressing the profound legal issues raised by induced pluripotent stem cells.|
|Safety of Induced Stem Cells Gets a Boost, NatureJanuary 9th, 2013A new paper could renew hopes of turning a patient’s own cells into perfectly matched replacement tissues, though differences in methodology between the study and clinical practice have left some eager for more proof.|
|RNL Bio Smuggled Out Stem Cells, The Korea TimesJanuary 3rd, 2013RNL Bio sent 15.5 billion won worth of stem cells to hospitals in China and Japan on 860 different occasions from November 2008 through July 2012 without reporting the shipments.|
|Stem Cell Controversy #1: Celltex and the FDA, Biopolitical TimesOctober 18th, 2012The FDA has warned Texas stem-cell treatment company Celltex, and the review board that approved its activities, that the company is illegally selling an unlicensed drug and violates good manufacturing practices.|
|Stem-Cell Fraud Hits Febrile Field, NatureOctober 16th, 2012As Hisashi Moriguchi's heart-treatment claims collapse, observers warn about the febrile nature of the iPS-cell field and caution against a rush to the clinic.
|The HealerHow Shinya Yamanaka Transformed the Stem-Cell War and Made Everyone a Winner, SlateOctober 9th, 2012Shinya Yamanaka's research on "induced pluripotent stem cells" earned him a Nobel Prize. But much of the media coverage missed half the story. Yamanaka’s venture wasn’t just an experiment. It was a moral project.|
|Sperm Precursor Cells Created in Lab, BioEdgeSeptember 7th, 2012Scientists may soon be able to create artificial sperm from a skin cell. Proponents extol benefits for sterile men; opponents warn of future obsolescence of males.|
|Patients Seek Stem-Cell Compensation, Nature NewsJuly 6th, 2012Six patients in California are suing RNL Bio, one of the world’s largest stem-cell companies, for allegedly misleading them about the effectiveness of its stem-cell treatments.|
|Will the FDA Close Down Celltex?
, Biopolitical TimesJune 28th, 2012An FDA report itemizes 79 specific problems with the Texas stem-cell company Celltex, and more trouble may be on the way.
|More Scandals in South Korea, Biopolitical TimesJune 8th, 2012Fresh accusations of stem-cell fraud, whose full extent is yet unknown, are rocking South Korea and threatening to damage the nation's reputation again. |
|California Considers DNA Privacy Law, NatureMay 18th, 2012California lawmakers are considering a bill that would require written consent for the collection, retention, and sharing of individual genetic information. Academic researchers fear the measures would prohibit work with genetic databases.
|Stem Cell Fraud Is the Real Issue in Texas, Biopolitical TimesMarch 2nd, 2012Bioethicist Glenn McGee has resigned from Celltex. His connection with the controversial stem-cell company has raised important issues about its business practices.|
|Rick Perry, Glenn McGee and Selling Texas Stem Cells, Biopolitical TimesFebruary 16th, 2012Gov. Perry is actively promoting an industry based on adult stem cells, in which Glenn McGee, until recently editor of the American Journal of Bioethics, is now employed. |
|Stem Cell Banking: The Newest Lure in Medical TourismArab princes and U.S. celebrities fly in for futuristic bio-care at Seoul "Life Center" , CNNFebruary 2nd, 2012In a new form of medical tourism, people from around the world are traveling to Seoul for stem cell treatments and to bank their stem cells, hoping that this will one day save their lives. |
|Geron Quits the Embryonic Stem Cell Industry, Biopolitical TimesNovember 16th, 2011Geron has cancelled its clinical trial of a stem-cell treatment for spinal cord injuries, raising questions about the future of the company and the industry.|
|Hwang Clones Coyotes, Scores Headlines, Biopolitical TimesOctober 19th, 2011Disgraced South Korean scientist Hwang Woo-Suk continues his efforts at rehabilitation by cloning endangered coyotes.|
|More on Cash for Eggs, Biopolitical TimesOctober 13th, 2011The Nuffield Council on Bioethics has issued a report about the provision of human bodily material for medicine and for research, including the issue of payment for gametes.|
|High-interest clones[Editorial]NatureOctober 6th, 2011Research into cloned human cells has left the specter of past scientific fraud behind. But reaction to the earlier work still holds worthwhile lessons.
|New Chair for California Stem Cell Agency, Biopolitical TimesJune 29th, 2011By a narrow margin, the CIRM board elected financier Jonathan Thomas as Chair, provoking significant criticism over his huge salary.|
|Setback for New Stem Cell Treatment, The New York TimesMay 13th, 2011Researchers reported on Friday that tissues made from induced pluripotent stem cells might be rejected by a patient’s immune system — even though the tissues would be derived from the same patient.|
|Stem Cell Strife in US and EU Courts, Biopolitical TimesMay 11th, 2011Developments in US and European courts regarding funding and oversight of stem cell research have reopened passionate debates.
|Bioethicists Show How to Disagree Without Rancor, Biopolitical TimesApril 19th, 2011Excerpts of a conversation between Arthur Caplan and Robert P. George demonstrate the possibility of constructive discussions about difficult ethical issues.|
|Europeans Want Regulation for Biotech, Biopolitical TimesNovember 18th, 2010The latest Eurobarometer report on biotechnology shows that Europeans, in general, support medical uses of technology as long as they are carefully regulated.|
|Another Korean Stem Cell Scandal? , Biopolitical TimesNovember 17th, 2010The Korean biotech company best known for trying to sell cloned dogs is now promoting stem cell tourism. It is also allegedly giving Korean lawmakers bargain-rate stem cell treatments in exchange for their help in easing regulations. |
|Science in the New York Times, Biopolitical TimesNovember 11th, 2010The anniversary issue of the Science Times section includes analysis and predictions as well as news.|
|60 Minutes on Stem Cells and Snake Oil, Biopolitical TimesSeptember 22nd, 201060 Minutes recently re-aired a story about stem cell con artists who play on the desperation of people with fatal degenerative diseases.|
|The Covenant, The New YorkerSeptember 6th, 2010Francis Collins, a fervent Christian, thought he had resolved the stem-cell debate. A federal judge disagreed.
|Stem Cell Education and Hype, Biopolitical TimesAugust 4th, 2010The embryonic stem cell lobby seems to be making a concerted effort to promote their technology.|
|FDA approves Geron's groundbreaking study of embryonic cells, Mercury NewsJuly 30th, 2010A Menlo Park biotech firm said Friday that federal regulators will let it proceed with the world's first human test of a treatment made from embryonic stem cells, a much-anticipated but controversial study of patients with spinal cord injuries that had been placed on hold for nearly a year because of safety concerns.
|Bending the Rules in California, Biopolitical TimesJune 16th, 2010Susanne Schultz recently investigated two organizations which may be skirting California's laws prohibiting payments to women to provide eggs for stem cell research.|
|Stem cells, human genes, and patents, Biopolitical TimesMay 14th, 2010A recent ruling on a stem cell patent is similar with concurrent challenges to patents on human genes related to breast cancer.|
|Selling With Stem Cells, Biopolitical TimesMarch 24th, 2010The Korean Food and Drug Administration (KFDA) is battling biotech companies over "stem cell cosmetics," some of which are already on sale in the U.S.|
|Hwang Tries for a Comeback, Biopolitical TimesFebruary 5th, 2010Hwang Woo-Suk is making active efforts to salvage his reputation, and to reestablish himself as a force in science.|
|Promises, Promises, The ScientistNovember 1st, 2009Ill-judged predictions and projections can be embarrassing at best and, at worst, damaging to the authority of science and science policy.|
|Symbol over Substance, GeneWatch (Sep-Oct 2009)Cloning-based stem cell research has been more symbol than substance; more moving target than realistic goal. But it has been a monkey wrench in the gears for progressive advocates of responsible biotechnologies.|
|The rise and fall of hybrids in the UK, Biopolitical TimesOctober 20th, 2009The remarkable push by UK researchers for animal-human hybrid embryos is another strange tale of science politics and science policy. |
|Susan Solomon's Stem Cell Spin, Biopolitical TimesSeptember 9th, 2009Last week, researchers reported a significant advance toward better understanding of--and potential treatments for--Type 1 diabetes. Yet strangely enough, one research advocate used it as an opportunity to praise a technique that this study not only didn't use, but also helped to refute.|
|Reactions to final NIH stem cell rules, Biopolitical TimesJuly 8th, 2009The final guidelines for federal funding of human embryonic stem cell research, which still exclude cloning-based work, received nearly unanimous support. Some backers had been more critical of the largely similar draft guidelines.
|Final federal stem cell rules welcomed by public interest groupCenter for Genetics and Society applauds expansion of funding; exclusion of cloning techniquesJuly 6th, 2009The Obama Administration and the National Institutes of Health have made the right call by expanding the funds available for responsible embryonic stem cell research, while excluding federal support for stem cell lines derived using cloning techniques.|
|California stem cell agency digs in deeper, Biopolitical TimesJuly 1st, 2009California's stem cell agency fights back against a call for reform by the state's independent "good government" agency-and threatens a lawsuit.|
|"A bad idea whose time has apparently come", Biopolitical TimesJune 23rd, 2009New York's stem cell program breaks with an international consensus, putting women's health at risk in order to pursue a discredited line of research.|
|"A conspiracy of hype", Biopolitical TimesMay 28th, 2009Bioethicist Alta Charo says that "there’s almost been a conspiracy of hype" in stem cell research.|
|Potential stem cell trouble in South Korea, Biopolitical TimesMarch 18th, 2009A team of researchers in South Korea has applied for approval to conduct cloning-based stem cell research. The concerns this raises should be placed in a wider context.|
|One more stem cell opinion, Biopolitical TimesMarch 13th, 2009Here's one more commentary that I wish to add to my recent compilation of opinions following the change in federal stem cell policy.|
|Stem Cell Decision Worries Some Scientists [Quotes CGS's Jesse Reynolds], New York TimesMarch 11th, 2009Obama's decision has removed the original raison d'être for the California program and others like it. And with most states facing severe budget pressures, it may prove difficult to justify spending the money.|
|Stem cell opinion round-up, Biopolitical TimesMarch 11th, 2009A collection of opinions from the first 48 hours after the change in federal human embryonic stem cell research policy.|
|Obama's Pledge to Science[Quotes CGS's Marcy Darnovsky], Inside Higher EdMarch 10th, 2009President Obama made good on his campaign promise to lift the restrictions on federal support for stem cell research.|
|Obama on stem cell policy change, Biopolitical TimesMarch 10th, 2009Yesterday's removal of restrictions on federal funding of human embryonic stem cell research by President Obama was both big and welcome news, and not just because the restrictions were unpopular and unduly restrictive.|
|More cloning, but still no stem cells, Biopolitical TimesFebruary 12th, 2009Three more research teams have created clonal human embryos, but none reported deriving stem cells from them.|
|Has change come to biology?Stem cell research under Obama, arts technicaFebruary 2nd, 2009The New York Stem Cell Foundation hosted a panel discussion of what the Obama administration might hold for stem cell research.|
|Always falling behind, Biopolitical TimesJanuary 23rd, 2009A new report concludes that the US is still the world leader in stem cell research. Although likely true, the report should be viewed skeptically.|
|A new tune for CAMR? Hopefully so., Biopolitical TimesJanuary 16th, 2009The Coalition for the Advancement of Medical Research (CAMR) seems to be trying to both cool the stem cell wars and to keep them alive|
|Federal Biotechnology Policy: Stem Cells and Beyond Center for Genetics and Society releases policy brief for the Obama AdministrationJanuary 14th, 2009In anticipation of an expected policy change by President-elect Barack Obama regarding federal funding for stem cell research, the Center for Genetics and Society has released a policy brief, "Responsible Federal Oversight of the New Human Biotechnologies: Opportunities for the New Administration."|
|Hwang to Back His Own Inventions, The Korea TimesJanuary 12th, 2009Getting a shot at redemption, Hwang's colleague at the Sooam Biotech Research Center confirmed that Seoul National University had handed over the intellectual property rights for Hwang's claimed inventions in human stem cell research to H-Bion.|
|Birds of a Feather, Biopolitical TimesDecember 18th, 2008In what may just be a match made in heaven, two controversial cloning-based stem cell research companies have formed a joint venture.|
|Next Steps for Progressive Stem Cell Politics, Science ProgressDecember 16th, 2008In the wake of the Bush administration’s policies, we will have the political space to craft a pro-research stand that simultaneously highlights the need for consistent and enforceable regulation, for hope without hype, and for developing human biotechnologies according to principles of social justice and human rights.|
|Vatican Ethics Guide Stirs ControversyChurch Decries Stem Cell Research, Infertility Treatments, The Washington PostDecember 13th, 2008The Vatican's first authoritative statement on reproductive science in 21 years triggered intense debate yesterday about some of the most contentious issues in modern biological research, including stem cells, designer babies, cloning, and a host of techniques widely used to prevent pregnancy and to help infertile couples have children.|
|Salary Plan at Stem Cell Institute Is CriticizedGovernor cites state deficit in opposing leaders' pay, The Union TribuneDecember 6th, 2008With the state facing a possible $28 billion deficit, Gov. Arnold Schwarzenegger has expressed “deep concern” about the state stem cell institute's plans to set the salaries for the chairman and vice chairman of its board, two positions for which no one has accepted pay in three years.|
|Couples in US Prefer to Donate Embryos for Research, Study FindsDuke University study shows that 41% of patients who finished fertility treatment consider donating embryosMcClatchy NewspapersDecember 4th, 2008The debate over embryonic stem cell research centres on the sanctity of life. But the couples who create the leftover embryos would rather they be destroyed in the course of scientific research than be given a chance at becoming babies.|
|CIRM won't give up on eggs for cloning-based work, Biopolitical TimesDecember 3rd, 2008The California stem cell research agency indicates that it will continue its recent push for women's eggs for cloning-based stem cell research, perhaps paying if necessary.|
|ACT, Korean Biotech Form New Stem Cell Joint VentureMass High TechDecember 2nd, 2008Worcester biotech Advanced Cell Technology Inc. and Korean biotech CHA Biotech Co. Ltd. have formed a new stem cell technology development company called Allied Cell Technology, to be based in Worcester. The international joint venture will use ACT’s hemangioblast cell technology to develop human blood cells.|
|Last Second Shot, Biopolitical TimesNovember 17th, 2008ESPN recently ran a web feature story and televised segment (see below) on NBA All- Star forward Carlos Boozer and his son’s struggle with sickle cell anemia.|
|Green's surprising turn on stem cells, Biopolitical TimesNovember 12th, 2008Does Ronald Green's new found moderation on stem cells represent a change in his perspective, or a shift to accommodate the changed political landscape, or something else?|
|RIP: Stem Cells in Politics (2002-2008), Biopolitical TimesNovember 5th, 2008Michigan may have passed its stem cell research initiative, but the real message from this election cycle is the end of embryonic stem cell research as a relevant political issue.|
|The Race Card in Michigan, Biopolitical TimesNovember 3rd, 2008Opponents of Proposal 2 tend to view embryos as an early form of human life and therefore see embryonic stem cell research as unethical human experimentation. To bolster their moral claim regarding the use of vulnerable subjects in scientific research, they are now comparing embryonic stem cell research to the Tuskegee experiment.|
|UK Grants All the Scientists' Wishes, Biopolitical TimesOctober 29th, 2008The bill overhauling the United Kingdom's oversight of assisted reproduction and embryo research granted researchers essentially all that they asked for, and then some.|